bioRxiv · 10.1101/2025.08.30.673184
Lysyl oxidase-dependent bone marrow stiffening promotes neutrophil activation in diabetes
Abstract
Persistent neutrophil activation contributes to the development of diabetic vascular complications in many organs including the retina. Past studies have implicated abnormal molecular or biochemical cues in neutrophil activation. Here we show that neutrophils can also be mechanically activated through an increase in bone marrow (BM) stiffness that results from diabetes-induced overexpression of matrix collagens and their crosslinker lysyl oxidase (LOX). Administration of LOX inhibitor {beta}-aminopropionitrile (BAPN) in diabetic mice concomitantly blocked BM matrix stiffening and neutrophil activation (superoxide generation and gp91phox upregulation), which predictably inhibited neutrophil cytotoxicity towards co-cultured retinal endothelial cells. Further, culturing neutrophils within BM-mimicking hydrogels of tunable stiffness indicate that matrix-localized and soluble LOX act synergistically to mechanochemically activate neutrophils in the BM. Thus, LOX-dependent changes in the BM physical environment offer a new mechanistic basis and therapeutic target for diabetic complications marked by neutrophil activation.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Agarwal, M., Chandrakumar, S., Trada, V., Srivastava, S., Ghosh, K.. 2025-09-04. Lysyl oxidase-dependent bone marrow stiffening promotes neutrophil activation in diabetes. https://doi.org/10.1101/2025.08.30.673184
Cite the original work for its findings. Save a collection to share your selection of sources.